Intrauterine fetal demise with caudal regression syndrome, a case report by McKissic, Devin A & Stockdale, Colleen K
Proceedings in Obstetrics and Gynecology, 2016;6(3):5 
 
Please cite this paper as: McKissic D, Stockdale CK. Intrauterine fetal demise with caudal regression syndrome, a 
case report. Proc Obstet Gynecol. 2016;6(3): Article 5 [ 6 p.]. Available from: http://ir.uiowa.edu/pog/. Free full text 
article. 
Corresponding author: Colleen Stockdale, MD, MS, Department of Obstetrics and Gynecology, 200 Hawkins Drive, 
Iowa City, IA 52246, Phone: 319-384-6849, Fax: 319-384-8620. Email:  colleen-stockdale@uiowa.edu  
Financial Disclosure: The authors report no conflict of interest. 
Copyright: © 2016 McKissic et al. This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited. 
1 
 
Intrauterine fetal demise with caudal regression syndrome,  
a case report 
Devin McKissic BS,1 Colleen K. Stockdale MD, MS2 
Key words: Intrauterine fetal demise, caudal regression syndrome, diabetes mellitus 
Abstract 
Background: The causes of intrauterine fetal 
demise are varied and not entirely well-
understood. Multiple observational studies have 
shown that both perinatal and infant mortality 
rates are increased in children of diabetic 
mothers when compared to those of nondiabetic 
mothers.  
Case: We present a case involving a 22-year-old 
G4P0120 with poorly controlled type 1 diabetes 
mellitus and a complex medical history including 
two first trimester fetal losses, and second 
trimester intrauterine fetal demise who 
presented during the second trimester for care 
and was found to have a fetus with ultrasound 
findings consistent with caudal regression 
syndrome. When she presented in labor at term 
intrauterine fetal demise was identified. 
Discussion: Infants and fetuses of diabetic 
mothers are at a higher risk for congenital 
anomalies, one of which is the potentially 
devastating caudal regression syndrome. 
However, it appears that this risk may be 
lowered with strict glycemic control both before 
and during pregnancy. 
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Introduction 
Fetal death, though relatively more 
prevalent in low- and middle-income 
countries, remains an issue in the 
United States with a fetal mortality rate 
(defined as fetal death at >20 weeks 
gestation) of 5.96 of 1000 live births and 
fetal deaths.1,2 Several risk factors for 
fetal death and stillbirth have been 
identified that allow practitioners to 
identify which patients may be at greater 
risk for these outcomes. Unmodifiable 
risk factors include nulliparity or 
multiparity ≤3, African, African-
Caribbean, Indian and Pakistani 
ethnicity, maternal history of mental 
health problems, and antepartum 
hemorrhage. Potentially modifiable risk 
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factors include smoking, maternal 
obesity, fetal growth restriction, and pre-
existing maternal diabetes.3 
The causes of fetal death are varied and 
not entirely well-understood. Identified 
causes include placental, fetal, and 
maternal abnormalities, but a significant 
percentage of fetal death remains 
idiopathic. Placental pathologies that 
may lead to fetal death include placental 
bed abnormalities (e.g. abruptio 
placentae), placental developmental 
abnormalities (e.g. placental 
hypoplasia), placental parenchyma 
abnormalities (e.g. fetal thrombotic 
vasculopathy), and umbilical cord 
abnormalities (e.g. knots, 
strangulation).4 Fetal abnormalities may 
be genetic, such as trisomy 18, or 
structural, such as spina bifida. Finally, 
maternal abnormalities leading to fetal 
death include systemic syndromes such 
as preeclampsia or diabetes as well as 
infection.5 
The fetuses and infants of women with 
diabetes are subject to higher rates of 
complications when compared to their 
counterparts with nondiabetic mothers. 
Multiple observational studies have 
shown that both perinatal and infant 
mortality rates are increased in children 
of diabetic mothers (particularly those 
with preexisting diabetes) when 
compared to those of nondiabetic 
mothers. Though complicated deliveries 
(as evidenced by higher levels of 
Caesarean sections and forceps or 
vacuum-assisted vaginal deliveries in 
diabetic women) likely contribute to this 
observation, the increased incidence of 
congenital anomalies in these fetuses 
and infants may have an even greater 
impact.6-10 
Case Report  
A 22-year-old G4P0120 with poorly 
controlled type 1 diabetes mellitus and a 
complex medical history including two 
first trimester losses, and recent 
induction of labor for a second trimester 
loss following presentation at 28 weeks 
with ultrasound revealing fetus at 20 3/7 
weeks with signs of significant fetal 
decomposition, presented for initial care 
at 26 1/7 weeks gestation. The dating 
ultrasound revealed a fetus with no 
lumbar or sacral spine, consistent with 
caudal regression syndrome (CRS). 
Medical history was significant for 
diabetes mellitus (diagnosed at 4 years 
of age) with multiple hospitalizations for 
diabetic complications, tobacco 
dependence, and subsequent urine drug 
screen positive for amphetamines at her 
35 week antenatal visit. 
Following the previous second trimester 
intrauterine fetal demise (IUFD) the 
patient underwent a comprehensive 
workup for antiphospholipid antibody 
syndrome and other thrombophilias, 
thyroid derangements, fetal 
hemorrhage, and infections including: 
cytomegalovirus, herpes simplex virus, 
parvovirus B19, and toxoplasmosis 
which was negative. Placental analysis 
by pathology showed a two-vessel 
umbilical cord, chorioamnionitis, amnion 
nodosum, mild increase in intervillous 
fibrin and microcalcifications. The 
patient denied fetal autopsy, and the 
IUFD was felt to be the result of poorly 
controlled maternal diabetes.  
The patient presented to labor and 
delivery at 38 4/7weeks gestation with 
increasing contractions and decreased 
fetal movement.  Fetal heart tones were 
absent on arrival and term IUFD was 
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confirmed via ultrasound.  Initial 
laboratory results were remarkable for 
blood sugar 210 mg/dL and elevated 
beta-hydroxybutyrate at 1.6 mmol/L 
(reference range less than 0.4-0.5 
mmol/L), with an anion gap of 18 mEq/L 
(reference range 3-11 mEq/L). Fluids 
and insulin were administered and a 
repeat beta-hydroxybutyrate was <0.1 
mmol/L.  
Labor and delivery were complicated by 
artificial rupture of membranes yielding 
thick, malodorous fluid, maternal fever 
to 38.0° consistent with chorioamnionitis 
requiring ampicillin and gentamicin, and 
shoulder dystocia. Delivery yielded a 
highly edematous fetus with small, 
bowed, and contracted lower 
extremities. Repeat IUFD workup for 
antiphospholipid antibody syndrome and 
thrombophilias, fetal hemorrhage, and 
thyroid derangements was normal. 
Placental analysis by pathology showed 
a two-vessel umbilical cord, acute 
chorionitis, and third trimester chorionic 
villi. She again declined fetal autopsy; 
the cause of the term IUFD was 
attributed to caudal regression 
syndrome in the setting of maternal 
diabetes.  
Discussion  
Fetal death can be a highly emotional 
event, which may make searching for 
and determining an etiology difficult. The 
American College of Obstetricians and 
Gynecologists (ACOG) recommends a 
thorough evaluation, including placental 
and umbilical cord examination, genetic 
analysis of the fetus, maternal screening 
for infection, lupus, and thyroid 
problems, and an autopsy if the family 
permits.11  
Women with diabetes may have 
pregnancies complicated by a variety of 
congenital anomalies, with cardiac 
anomalies being the most common. 
Anomalies of the musculoskeletal 
system, central nervous system, 
genitourinary system, and ear, nose, 
and throat may also be seen.6, 7 No 
anomaly appears to be pathognomonic 
for infants of mothers with diabetes; 
however, the anomaly that comes 
closest, with a relative risk of 200-400, is 
CRS.6 Yet many cases of CRS occur in 
fetuses and infants whose mothers do 
not have diabetes, with approximately 
22% of CRS cases occurring with 
diabetic mothers.12 
Caudal regression syndrome was first 
described by Duhamel in 1961.13 It is 
characterized by varying levels of 
sacrococcygeal or lumbosacrococcygeal 
agenesis, which may be accompanied 
by abnormalities or hypoplasia of the 
pelvis and legs.14 The diagnosis of CRS 
may be made early in gestation with 
sonographic recognition of a decreased 
crown-rump length. Later, sonographic 
evaluation will yield evidence of a 
shortened spine with deficits in the 
lumbar and sacral regions, short femora, 
and flexion contractures of the lower 
extremities.15 If diagnostic uncertainty 
remains, or further evaluation is 
necessary, amnioinfusion or MRI may 
be helpful to better visualize fetal 
structures.14, 16  
In addition to the classic “frog-leg” 
presentation due to the flexion 
contractures of the lower extremities,12 
CRS has also been associated with 
abnormalities of the urinary tract, 
genitalia, and anorectal area. One 
particular constellation of such 
abnormalities is known as the OEIS 
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complex: omphalocele, exstrophy of the 
bladder, imperforate anus, and spinal 
defects.14, 17 
The prognosis for infants with CRS is 
variable, and somewhat dependent 
upon the degree of sacral agenesis. 
Infants with complete sacral agenesis 
are at a higher risk for complications 
and early neonatal death. All will need a 
thorough evaluation after birth by 
urology and orthopedics, as well as for 
any other anomalies they may have. 
Those who survive past infancy tend to 
have long term problems due to 
neurogenic vesicopathy and 
neuromuscular deficits in the lower 
extremities.16 
The pathogenesis of CRS is poorly 
understood. It likely arises from an issue 
with the gastrulation process leading to 
a defect in the mesoderm and induction 
of caudal elements in the embryo before 
the 4th week of gestation.12, 14 Several 
gene/protein pathways, including the 
Shh, Cdx2, Acd, and Lrp6 pathways 
appear to be involved.14 It has also been 
suggested that in mothers with diabetes, 
hyperglycemia leads to decreased 
myoinositol intake in the embryo, which 
in turn may cause abnormal fusion and 
folding events in the embryo.12 It is likely 
that the pathogenesis of CRS is 
multifactorial, with both genetic and 
environmental components.  
Though the infants of diabetic mothers 
do tend to have higher rates of 
anomalies, they are not doomed to this 
fate. Multiple studies have shown that 
while mothers with higher glycated 
hemoglobin levels early in pregnancy 
have higher rates of fetal anomalies, 
tight glycemic control both before and 
throughout the pregnancy may decrease 
these rates.18-21 Therefore, pregnant 
women with diabetes should be 
counseled extensively about the 
benefits of maintaining good control of 
their diabetes.   
Conclusion  
Infants and fetuses of diabetic mothers 
are at a higher risk for congenital 
anomalies, one of which is the 
potentially devastating caudal 
regression syndrome. However, it 
appears that this risk may be lowered 
with strict glycemic control both before 
and during pregnancy. While the vast 
majority of healthcare providers 
encourage tight glycemic control in their 
pregnant patients with diabetes, efforts 
should be made to find ways to improve 
patient compliance in order to reduce 
the incidence of CRS and other diabetic 
complications. 
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